Fenwick recently announced the opening of an office in New York, joining established offices in Silicon Valley, San Francisco, Seattle and Shanghai. Fueling the move was growing demand from our existing New York client base and the opportunity to better serve the needs of the region’s technology and life sciences innovators and investors.
The New York Law Journal noted the firm is already active in the New York legal market, and “is poised to compete directly with New York firms for lucrative tech transactions and life sciences matters involving established institutions and the city's thriving startup community.”
“The timing is right for us,” Fenwick chair Richard Dickson told The Wall Street Journal. “In the last five years or so, the amount of venture investment into the technology and life sciences space in New York has more than quadrupled.”
Bloomberg BNA said the move to New York “illustrates how the New York emerging company and technology market has made the city attractive to outside law firms looking to advise financial institutions and private equity firms involved in tech deals, startups, as well as companies in other industries — media, retail, advertising and entertainment — seeking to blend new forms of technology with their businesses.”
The firm’s New York office will “continue Fenwick’s core business of representing technology and life sciences companies in corporate work and tech transactions,” Dickson told The Recorder.
“I’m confident in what we’re building around,” Dickson told Bloomberg. “I’ve never seen an investment proposed within our partnership that has had more broad support from our partnership as a whole. I think that bodes very well for our success.”